3种方案治疗细菌性阴道病的成本-效果分析  

Cost-Effectiveness Analyses of Three Therapeutic Schemes for Bacterial Vaginosis

作　　者：李艳[1] 胡斌[1] 

机构地区：[1]西安市第四医院药剂科,西安市710004

出　　处：《中国医院用药评价与分析》2009年第2期131-132,共2页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:探讨不同用药方案对于治疗细菌性阴道病所产生的经济学效果。方法:180例门诊细菌性阴道病患者随机分为3组,分别给予阴道用乳酸杆菌活菌胶囊10d(A组),口服奥硝唑6d(B组),在口服奥硝唑6d后用阴道用乳酸杆菌活菌胶囊10d(C组),运用药物经济学方法进行成本-效果分析。结果:3组有效率分别为85.0%、86.7%、96.7%;成本分别为90.1元、98.8元、130.9元;成本-效果比分别为106.00、113.96、135.37;B、C组相对于A组的增量成本-效果比分别为511.76、348.72。结论:C组方案较佳。OBJIECTIVE： To evaluate the economic effectiveness of different therapeutic schemes for bacterial vaginosis. METHODS： 180 outpatients with bacterial vaginosis were randomly divided into 3 groups： Group A were assigned to receive Viable Capsule of Lactobacillus for 10 days, Group B to receive oral Omidazole Tablets for 6 days, and Group C to receive oral Ornidazole Tablets for 6 days followed by taking Viable Capsule of Lactobacillus for 10 days. The cost - effectiveness analyses were performed using the method of pharmacoeconomics. RESULTS ： The effective rates for Group A, B and C were 85.0%, 86.7% and 96.7%, respectively; the total costs in the 3 groups were 90.1 yuan, 98.8 yuan and 130.9 yuan, respectively, and the cost- effectiveness ratios were 106.00, 113.96 and 135.37, respectively. As compared with Group A, the incremental costs - effectiveness ratios for Group B and Group C were 511.76 and 348.72, respectively. CONCLUSION： Group C is the best one in terms of cost - effectiveness.

关 键 词：细菌性阴道病 药物经济学 成本-效果分析 

分 类 号：R978.1[医药卫生—药品]